Allison Kurian, MD, Oncology, Palo Alto, CA

AllisonWalshKurianMDMSc

Oncology Palo Alto, CA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment

Professor, Medicine - Oncology and Epidemiology & Population Health, Stanford University School of Medicine

Dr. Kurian is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kurian's full profile

Already have an account?

Education & Training

  • Stanford University School of Medicine
    Stanford University School of MedicineM.Sc., 2004 - 2006
  • Stanford University
    Stanford UniversityFellowship, Medical Oncology, 2002 - 2003
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
  • Harvard Medical School
    Harvard Medical SchoolClass of 1999
  • Stanford University
    Stanford UniversityB.A., 1991 - 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2021
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Risk-Reducing Salpingo-Oophorectomy with Breast Cancer Risk in Women with BRCA1 and BRCA2 Pathogenic Variants  
    Mary B Daly, Sarah Colonna, Saundra S Buys, Allison W Kurian, JAMA Oncology
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing  
    William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health

Lectures

  • Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Genetic testing and results in population-based breast cancer patients and ovarian cancer patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

  • Genetic Testing May Benefit Older Women with Breast Cancer
    Genetic Testing May Benefit Older Women with Breast CancerApril 1st, 2020
  • DNA Tests Can Guide Breast Cancer Treatment, While Also Raising Questions We Can’t yet Answer
    DNA Tests Can Guide Breast Cancer Treatment, While Also Raising Questions We Can’t yet AnswerMarch 31st, 2020
  • Prevalence of Pathogenic Variants in Postmenopausal Breast Cancer
    Prevalence of Pathogenic Variants in Postmenopausal Breast CancerMarch 19th, 2020
  • Join now to see all

Professional Memberships